Director/PDMR Shareholding
24 February 2023 11:00 GMT Transaction by Person Discharging Managerial Responsibilities AstraZeneca PLC (the Company) announces that, on 22 February 2023, it was notified by Aradhana Sarin, Executive Director and Chief Financial Officer, that, on 17 February 2023, Dr Sarin ceased to be beneficially interested in 200 American Depositary Shares (ADSs) of the Company, following the gift of those shares to charity for nil consideration. Each ADS represents one half of an ordinary share of $0.25 each in the Company. Further details are set out in the attached notification, made in